Method for amplifying nucleic acid and analysis of single-nucleotide polymorphism using the same
First Claim
Patent Images
1. A method for amplifying a nucleic acid comprising:
- preparing an oligonucleotide being capable of complementarily hybridizing with a specific region of a target nucleic acid containing at least one mutation site, the oligonucleotide having at least one non-complementary sequence being not complementary to any of possible sequences of the at least one mutation site;
subjecting the oligonucleotide to hybridization with the target nucleic acid; and
carrying out a complementary-strand synthesis.
1 Assignment
0 Petitions
Accused Products
Abstract
A method amplifies a nucleic acid by preparing an oligonucleotide being capable of complementarily hybridizing with a specific region of a target nucleic acid containing at least one mutation site, the oligonucleotide having at least one sequence being non-complementary to any of possible sequences of the at least one mutation site, subjecting the oligonucleotide to hybridization with the target nucleic acid, and carrying out a complementary-strand synthesis. A single-nucleotide polymorphism is analyzed using this method.
13 Citations
14 Claims
-
1. A method for amplifying a nucleic acid comprising:
-
preparing an oligonucleotide being capable of complementarily hybridizing with a specific region of a target nucleic acid containing at least one mutation site, the oligonucleotide having at least one non-complementary sequence being not complementary to any of possible sequences of the at least one mutation site;
subjecting the oligonucleotide to hybridization with the target nucleic acid; and
carrying out a complementary-strand synthesis. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A kit for amplifying a nucleic acid and/or for analyzing a single-nucleotide polymorphism, comprising an oligonucleotide primer or probe being capable of complementarily hybridizing with a specific region of a target nucleic acid containing at least one mutation site,
wherein the oligonucleotide primer or probe has at least one non-complementary sequence being not complementary to any of possible sequences of the at least one mutation site.
Specification